Enoblituzumab, previously known as TJ-271 or MGA271, represents a innovative monoclonal directed at CD33, an marker found predominantly on blood populations. This molecule functions as a dual-action molecule, https://teganfjfr118881.blog-gold.com/58277992/enoblituzumab-a-deep-dive-into-tj-271-and-mga271